475 Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockadeNamrata S. Patil, David S. Shames, Raymond D. Meng et al.|Regular and Young Investigator Award Abstracts|2022Cited by 3
Anti-TIGIT antibody tiragolumab improves PD-L1 blockade via myeloid and Treg cellsXiangnan Guan, Pallavi Daggumati, Lisa McGinnis et al.|The Journal of Immunology|2024Cited by 1
Abstract 5712: Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockadeNamrata S. Patil, David S. Shames, Shyam Srivats et al.|Cancer Research|2023Cited by 0